THE Medicines Control Authority of ZimbaÂbwe (MCAZ) has approved the use of the new twice-yearly HIV prevention drug, lenacapavir. This comes as...
To access this content, please purchase a subscription by clicking the button below and select a package of your choice!
Subscriptions